Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SERA | SERA PROGNOSTICS, INC. | Director | $147K | -$5.48K | -3.6% | Apr 7, 2025 |
ACRV | Acrivon Therapeutics, Inc. | Chief Medical Officer | $0 | Apr 9, 2025 | ||
KPTI | Karyopharm Therapeutics Inc. | Director | May 29, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|